Recruitment

Recruitment Status
Not yet recruiting
Estimated Enrollment
36

Summary

Conditions
  • Cancer of the Pancreas
  • Pancreas Adenocarcinoma
  • Pancreas Cancer
Type
Interventional
Phase
Phase 2
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04331041
Collaborators
  • National Cancer Institute (NCI)
  • Verastem, Inc.
Investigators
Principal Investigator: Hyun Kim, M.D. Washington University School of Medicine